Stock OCGN OCUGEN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Ocugen, Inc.

Equities

OCGN

US67577C1053

Real-time Estimate Cboe BZX
Other stock markets
 12:34:57 2024-05-21 pm EDT 		5-day change 1st Jan Change
1.845 USD -3.91% Intraday chart for Ocugen, Inc. +8.82% +221.74%
May. 15 Ocugen Completes Dosing of Second Group in Stargardt Eye Therapy Safety and Efficacy Study MT
May. 15 Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST?A Modifier Gene Therapy CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
GL
ROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN
PR
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
PR
Ocugen Completes Dosing of Second Group in Stargardt Eye Therapy Safety and Efficacy Study
MT
Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy
GL
Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST?A Modifier Gene Therapy
CI
IMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm
PR
ROSEN, A LEADING LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN
NE
Transcript : Ocugen, Inc., Q1 2024 Earnings Call, May 14, 2024
Ocugen Provides Business Update with First Quarter 2024 Financial Results
GL
Ocugen: Q1 Earnings Snapshot
AQ
Ocugen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
OCUGEN TO PRESENT AT MAY 2024 INVESTOR CONFERENCES
AQ
OCUGEN ANNOUNCES DISTRIBUTION OF SERIES C PREFERRED STOCK TO HOLDERS OF ITS COMMON STOCK
AQ
ROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN
PR
Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
GL
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
PR
Ocugen to Present at May 2024 Investor Conferences
GL
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN
NE
OCUGEN TO HOST CONFERENCE CALL ON TUESDAY, MAY 14 AT 8:30 A.M. ET TO DISCUSS BUSINESS UPDATES AND FIRST QUARTER 2024 FINANCIAL RESULTS
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OCGN Stock
  4. News Ocugen, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW